
Debiopharm
@debiopharmnews
We are an independent biopharmaceutical company with an ongoing commitment to improve patient outcomes & quality of life in oncology & bacterial infections
ID: 1617968917
http://www.debiopharm.com 24-07-2013 14:55:18
850 Tweet
741 Followers
99 Following




Today, we're celebrating great news for the future of #cancer patients! The worldwide development and commercialization rights for our first-i-class, peptide-based #radioligandtherapy programs have exclusively been licensed to ITM Isotope Technologies Munich SE! 🎉 bit.ly/3zhOcUE #biotech

A special thank you to our investigators Michael Hofman and Dr. Darren Feldman for their ongoing collaboration to advance radioligand therapy development 🙌





